A Win For Cleveland BioLabs, Inc.

Tue 14 Jul 20 at 05:30 PM
A Win For Cleveland BioLabs, Inc.

Cleveland BioLabs, Inc. (CBLI:NASDAQ) jumped higher at $3.27, representing a gain of 57.2%. On Mon 13 Jul 20, CBLI:NASDAQ touched a New 2-Week Low of $2.08. From Mon 29 Jun 20, the stock recorded 22.22% Up Days and 40.00% Green Days

The stock spiked on Fri 26 Jun 20 at $4.43 with a volume of 51M+, and its share price has been moving sideways in recent weeks.

About Cleveland BioLabs, Inc. (CBLI:NASDAQ)

Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.